These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1485594)

  • 1. Expression of the epidermal growth factor receptor in squamous carcinoma cell lines of the larynx and hypopharynx.
    Bujía J; Wustrow TP
    Allergol Immunopathol (Madr); 1992; 20(4):152-6. PubMed ID: 1485594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterologous epidermal growth factor receptor (EGF-R) expression in larynx cancer cell lines: evidence for the existence of structurally modified receptors.
    Bujía J; Wustrow TP
    Acta Otolaryngol; 1993 Nov; 113(6):789-92. PubMed ID: 8291440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variations of EGF-R surface expression in squamous cell carcinomas of the head and neck region.
    Mandic R; Eikelkamp N; Peldszus R; Sadowski M; Sesterhenn AM; Dünne AA; Werner JA
    Anticancer Res; 2001; 21(5):3413-8. PubMed ID: 11848502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification of the int-2 gene in human head and neck squamous cell carcinomas.
    Somers KD; Cartwright SL; Schechter GL
    Oncogene; 1990 Jun; 5(6):915-20. PubMed ID: 2193294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the autocrine transforming growth factor alpha pathway in human squamous carcinoma cells.
    Reiss M; Stash EB; Vellucci VF; Zhou ZL
    Cancer Res; 1991 Dec; 51(23 Pt 1):6254-62. PubMed ID: 1933886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted disruption of the epidermal growth factor receptor inhibits development of papillomas and carcinomas from human papillomavirus-immortalized keratinocytes.
    Woodworth CD; Gaiotti D; Michael E; Hansen L; Nees M
    Cancer Res; 2000 Aug; 60(16):4397-402. PubMed ID: 10969784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrin deposition in squamous cell carcinomas of the larynx and hypopharynx.
    Bárdos H; Juhász A; Répássy G; Adány R
    Thromb Haemost; 1998 Nov; 80(5):767-72. PubMed ID: 9843169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.
    Piyathilake CJ; Frost AR; Manne U; Weiss H; Bell WC; Heimburger DC; Grizzle WE
    Clin Cancer Res; 2002 Mar; 8(3):734-44. PubMed ID: 11895903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.
    Fischer C; Zlobec I; Stöckli E; Probst S; Storck C; Tornillo L; Lugli A; Wolfensberger M; Terracciano L
    Hum Pathol; 2008 Oct; 39(10):1527-34. PubMed ID: 18620726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated epidermal growth factor receptor gene copy number and expression in a squamous carcinoma cell line.
    Merlino GT; Xu YH; Richert N; Clark AJ; Ishii S; Banks-Schlegel S; Pastan I
    J Clin Invest; 1985 Mar; 75(3):1077-9. PubMed ID: 2984254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
    O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
    Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck.
    Rubin Grandis J; Melhem MF; Barnes EL; Tweardy DJ
    Cancer; 1996 Sep; 78(6):1284-92. PubMed ID: 8826952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human laryngeal primary and metastatic squamous cell carcinoma cell lines UM-SCC-17A and UM-SCC-17B.
    Carey TE; Van Dyke DL; Worsham MJ; Bradford CR; Babu VR; Schwartz DR; Hsu S; Baker SR
    Cancer Res; 1989 Nov; 49(21):6098-107. PubMed ID: 2790823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumor activity of monoclonal antibody CIBCNSH3 generated to the human EGF receptor.
    Udayachander M; Dean CJ; Meenakshi AN; Sivakumar N; Babu PB; Sivakumar J
    Hum Antibodies; 1997; 8(2):60-4. PubMed ID: 9289389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx.
    Järvinen AK; Autio R; Kilpinen S; Saarela M; Leivo I; Grénman R; Mäkitie AA; Monni O
    Genes Chromosomes Cancer; 2008 Jun; 47(6):500-9. PubMed ID: 18314910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand activation of overexpressed epidermal growth factor receptor results in colony dissociation and disturbed E-cadherin function in HSC-1 human cutaneous squamous carcinoma cells.
    Fujii K; Furukawa F; Matsuyoshi N
    Exp Cell Res; 1996 Feb; 223(1):50-62. PubMed ID: 8635495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor.
    Modjtahedi H; Eccles S; Sandle J; Box G; Titley J; Dean C
    Cancer Res; 1994 Apr; 54(7):1695-701. PubMed ID: 8137284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of epidermal growth factor receptor induced by alpha-interferon in human epidermoid cancer cells.
    Budillon A; Tagliaferri P; Caraglia M; Torrisi MR; Normanno N; Iacobelli S; Palmieri G; Stoppelli MP; Frati L; Bianco AR
    Cancer Res; 1991 Feb; 51(4):1294-9. PubMed ID: 1997168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of anti-epidermal growth factor receptor monoclonal antibodies and cisplatin in ten human head and neck squamous cell carcinoma lines.
    Hoffmann T; Hafner D; Ballo H; Haas I; Bier H
    Anticancer Res; 1997; 17(6D):4419-25. PubMed ID: 9494544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.